Summary
1Q revenue grew +69.3% YoY, and the operating loss narrowed on a lower SG&A ratio. However, the full-year plan (Operating Income of JPY 50M, adjusted EBITDA of JPY 324M) requires a return to profitability from 2Q onward. The first focus in 2Q is whether revenue momentum, including contributions from M&A-acquired brands, continues. The second is whether Gross Profit Margin, which declined YoY in 1Q, recovers. We will then look for SG&A growth to stay within the pace of revenue growth and for the adjusted EBITDA loss to narrow. The company's filings still flag material events related to the going-concern assumption. As a result, 1H cumulative operating CF and cash on hand are as important to monitor as the earnings recovery.
Key Points for Next Quarter
| Key Points & Focus | Implications |
|---|---|
Revenue Growth1H cumulative revenue progress vs. the full-year plan and the level of standalone 2Q revenue | Achieving the full-year plan of JPY 6,602M requires average quarterly revenue of JPY 1,762M over 2Q-4Q (our estimate). We will compare standalone 2Q revenue with both 1Q actual of JPY 1,317M and the prior-year quarter's JPY 829M (our estimate) to gauge how close it is to the plan trajectory. |
Gross Margin StructureYoY and QoQ trend in Gross Profit Margin | 1Q Gross Profit Margin was 50.6%, below the prior-year level of 53.0% (our estimate). A move toward the prior-year standalone 2Q level of 55.6% (our estimate) would confirm an improving brand mix. |
Earnings RecoveryNarrowing of adjusted EBITDA and operating losses; SG&A ratio trend | 1Q adjusted EBITDA was -JPY 63M, and reaching the full-year plan of JPY 324M requires +JPY 387M over 2Q-4Q (our estimate). Whether the 1Q SG&A ratio of 61.3% (73.7% in the prior-year quarter, our estimate) can fall further will indicate the path to profitability. |
Cash Generation1H cumulative operating CF and trend in cash and deposits | Operating CF in the previous fiscal year was -JPY 154M for 1H and -JPY 676M for the full year. The change from 1Q-end cash and deposits of JPY 521M, along with the sign of operating CF, will serve as indicators of progress toward resolving the going-concern-related material events. |
Key Issues from Previous Results (FY3/27 1Q)
1Q revenue was JPY 1,317M (+69.3% YoY). The operating loss narrowed to -JPY 141M (vs. -JPY 161M in the prior-year quarter), and adjusted EBITDA improved to -JPY 63M (vs. -JPY 113M). However, income taxes of JPY 25M widened the quarterly Net Income Attributable to Owners of Parent Company loss to -JPY 177M (vs. -JPY 115M). The company kept its full-year plan unchanged. 2Q is therefore the first checkpoint for whether the company can deliver both revenue growth and earnings improvement in line with its turnaround plan. Medium-term management plan targets are not disclosed in the earnings release.
1. Sustaining Revenue Momentum and Progress Toward the Full-Year Plan
- Last Quarter: 1Q revenue was JPY 1,317M (+69.3% YoY), representing 19.9% progress against the full-year plan of JPY 6,602M (our estimate).
- What to Check This Quarter: Whether Kanarabo and other entities consolidated from FY3/26 3Q (November 2025) are contributing to YoY growth.
- Key Metrics: Compare standalone 2Q revenue with 1Q actual of JPY 1,317M and the prior-year quarter's JPY 829M (our estimate). 1H cumulative revenue in the previous fiscal year was JPY 1,607M, or 38.9% of full-year actual (our estimate); we will benchmark this year's 1H progress rate against it.
2. Room for Gross Profit Margin Recovery
- Last Quarter: 1Q Gross Profit of JPY 666M (+61.5% YoY) grew more slowly than revenue, with Gross Profit Margin at 50.6% (53.0% in the prior-year quarter).
- What to Check This Quarter: Whether the margin decline stems from the cost structure of acquired brands or shifts in channel mix. Whether management indicates margin improvement in 2Q is also a key focus.
- Key Metrics: Compare standalone 2Q Gross Profit Margin with both the prior-year standalone 2Q level of 55.6% and the 1Q actual of 50.6% (both our estimates).
3. SG&A Efficiency and the Improvement Trajectory for Adjusted EBITDA and Operating Income
- Last Quarter: SG&A rose +40.7% YoY to JPY 807M but grew more slowly than revenue, lowering the SG&A ratio to 61.3% (73.7% in the prior-year quarter) (our estimate). Goodwill amortization increased to JPY 54M (JPY 18M in the prior-year quarter).
- What to Check This Quarter: Whether cost savings from the company's streamlining of group headquarters functions are curbing SG&A growth. 1Q booked income taxes of JPY 25M despite a pre-tax loss, so we will examine the breakdown of extraordinary items and income taxes.
- Key Metrics: The full-year Operating Income plan of JPY 50M requires +JPY 191M over 2Q-4Q, and the adjusted EBITDA plan of JPY 324M requires +JPY 387M over the same period (our estimate). Benchmarks are 1H cumulative adjusted EBITDA and operating income (prior-year 1H operating loss of -JPY 203M), and whether the full-year plan is maintained.
4. Operating CF and Financial Position
- Last Quarter: 1Q-end cash and deposits stood at JPY 521M (-JPY 167M vs. the previous fiscal year-end), with an Equity Ratio of 16.5% (19.2% at the previous fiscal year-end). Interest-bearing debt, including lease obligations, was JPY 3,342M (our estimate). 1Q interest expense was JPY 19M, up +93.8% YoY (our estimate).
- What to Check This Quarter: Operating CF was negative for two consecutive fiscal years through the previous year, and the going-concern-related disclosure remains in place. The company states that it has secured a path to funding for the current fiscal year, so we will look for updates on 2Q financing and improvement in operating CF.
- Key Metrics: 1H cumulative operating CF (-JPY 154M in the prior-year period), 2Q-end cash and deposits (JPY 521M at 1Q-end), Equity Ratio (16.5% at 1Q-end), and net assets (JPY 883M at 1Q-end).
Key Timely Disclosures During the Current Fiscal Year
- 2026/10/16Oral facial device "MiiS LIFT BRUSH" wins eight titles on Qoo10, including No. 1 in the overall ranking - The company expects cumulative sales through end-October to reach 3.48x the original plan. Since the bulk of the contribution falls in 3Q (Oct-Dec) and beyond, we will watch how it is reflected in the full-year outlook at 2Q results.
- 2026/10/07Kanarabo's EC sales surge after joining MUSCAT GROUP; average monthly sales over the past three months reach approximately 2.8x the level immediately after joining - Average monthly EC sales for Jul-Sep were approximately 2.8x those of November 2025-January 2026, the period immediately after joining. With the period coinciding with 2Q, the key question is whether PMI results show up in standalone 2Q revenue and Gross Profit Margin.
- 2026/08/28Fujiko "Keana Odamari! Cream" surpasses approximately 230,000 cumulative units sold within five months of launch - Unit sales are approximately 2.8x the original forecast, and the product is in short supply nationwide. Alongside its 2Q revenue contribution, we will look to management commentary for any inventory or supply constraints. The expansion to approximately 9,000 retail stores announced on 9/17 is an issue that will be reflected from 3Q onward.
Previous Quarter Results (FY3/27 1Q Actual)
The company operates as a "brand produce company," running its own brands, expanding its brand portfolio through M&A, and supporting client companies. It reports a single Brand Produce segment comprising eight consolidated subsidiaries, centered on WinC, Rice Curry Plus, Matsumura Shoten, and Kanarabo. For the current fiscal year, it plans revenue of JPY 6,602M (+59.9% YoY) driven by contributions from M&A-acquired brands, and targets a return to profitability with Operating Income of JPY 50M. In 1Q, revenue grew and the operating loss narrowed, but the bottom-line loss widened YoY due to the tax burden.
| Item | Amount | YoY | vs. Company Plan | Notes |
|---|---|---|---|---|
| Revenue | JPY 1,317M | +69.3% | - | 19.9% progress vs. full-year plan (our estimate) |
| Operating Income | -JPY 141M | - | - | Loss narrowed from -JPY 161M in the prior-year quarter. SG&A ratio of 61.3% (our estimate) |
| Recurring Profit | -JPY 151M | - | - | -JPY 167M in the prior-year quarter. Interest expense of JPY 19M |
| Quarterly Net Income Attributable to Owners of Parent Company | -JPY 177M | - | - | Income taxes of JPY 25M booked. Negligible extraordinary items |
| EPS | -JPY 51.84 | - | - | -JPY 38.79 in the prior-year quarter |
Progress vs. Full-Year Plan (Operating Income Basis): Not calculable (1Q operating loss of -JPY 141M vs. full-year plan of JPY 50M) (prior-year quarter: not calculable due to 1Q operating loss of -JPY 161M). No full-year Recurring Profit plan has been disclosed. For reference, revenue progress stands at 19.9% (our estimate).
ENVALITH, INC. ("ENVALITH") provides exclusive research coverage services to domestic and international institutional investors, as well as domestic individual investors, with the objective of contributing to the development of global and Japanese capital markets by providing information necessary for considering investments in Japanese listed companies.
- Purpose and Disclaimer Regarding Investment Decisions
This report has been prepared solely for informational purposes and does not constitute a solicitation to acquire, sell, or hold securities or any other financial products. Furthermore, this report does not constitute specific investment, financial, or tax advice. Any opinions, judgments, or recommendations contained herein are not intended to induce investment activities. Please be advised that all investment decisions must be made based on the investor's own responsibility and judgment, and ENVALITH and subject company shall not be involved in any such investment decisions.
- Information Sources, Accuracy, and Disclaimer of Warranty
This report has been prepared based on a formal request from the subject company, utilizing information provided by and interviews conducted with said company. By using this report, you are deemed to have agreed to the following: 1. Information Sources: This report is prepared on the assumption that the publicly available information and information disclosed by the subject company and provided during interviews is true and reliable. ENVALITH has not independently verified or validated the veracity of such information. 2. Accuracy: The interpretations, analyses, and hypotheses or conclusions based thereon contained in this report are independently derived by ENVALITH using its own perspectives and analytical methods based on the information mentioned in the preceding paragraph. 3. Disclaimer of Warranty: In the event that there are errors or omissions in the information disclosed by the subject company, ENVALITH and subject company shall not be held liable for any inaccuracies in this report resulting therefrom. ENVALITH and subject company make no warranties, whether express or implied, regarding the accuracy, safety, validity, completeness, or any other aspect of this report, nor regarding the past or future performance of the subject company.
- Limitation of Liability
ENVALITH and subject company shall not be liable for any costs, damages, or losses (including direct, indirect, incidental, consequential, or punitive damages) arising from the use of this report or the information obtained therefrom. Users of this report acknowledge and agree that such use is at their own risk.
- Potential Conflicts of Interest
ENVALITH may have, or may have in the future, business relationships with the subject company. Accordingly, investors should be aware that conflicts of interest may exist that could affect the objectivity of this report.
- No Obligation to Change or Update Content
The contents and opinions in this report, as well as the information upon which it is based, are current as of the date of preparation and are subject to change without notice. Please be advised that ENVALITH is under no obligation to update the contents of this report, and investors must verify the timeliness of the information on their own.
- Governing Language
This report is prepared in Japanese, English, and Chinese. In the event of any discrepancy or difference in interpretation between the language versions, the Japanese version shall be treated as the original and shall prevail.
- Copyright
All rights (including copyrights) relating to this report belong to ENVALITH. Any reproduction, redistribution, or other use of all or part of this report without the prior written permission of ENVALITH is strictly prohibited.
- Use for Other Investment Products
Except where ENVALITH has provided prior written approval, the use of this report and the trademarks or trade names of ENVALITH or the subject company in connection with the information distribution, transaction, sales promotion, or advertising of any investment products (including derivatives, structured products, investment trusts, or investment assets whose price, return, or performance is based on or linked to this report) is strictly prohibited.